RHY 4.76% 6.0¢ rhythm biosciences limited

Ann: RHY Advances Platform Expansion with Other Cancers, page-10

  1. 4,340 Posts.
    lightbulb Created with Sketch. 2629
    Yes, encouraging update. They continue to make progress but no money ball yet.

    I think it interesting that the statement refers to "pan-cancerous" as I am fairly sure that in a recent interview Glenn put the kibosh on any talk like that, insisting that each of the cancers will be addressed individually. I cannot track the interview down so maybe I have my wires crossed. But at the time I thought he was mindful of the bad connotations from the recent Theranos trials which showed that Elizabeth Holmes had rigged results from her pan-disease testing system.

    I hope Glenn and Otto take it a step at a time as even if they can bring just one of the other cancers into scope that would be a massive victory. So, one at a time. Having commercialised tests for colon cancer and just one of the other cancers would make Rhythm a superstar. No need to get too greedy and over-promise.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.003(4.76%)
Mkt cap ! $14.91M
Open High Low Value Volume
6.3¢ 6.3¢ 6.0¢ $1.647K 26.15K

Buyers (Bids)

No. Vol. Price($)
3 219243 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 6000 1
View Market Depth
Last trade - 15.34pm 12/07/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.